Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: Results from a cohort study from the dialysis registry in Japan

American Journal of Kidney Diseases

Volumn 59, Issue 1, 2012, Pages 108-116

  Fukuma, Shingo ^a   Yamaguchi, Takuhiro ^b   Hashimoto, Seiji ^c   Nakai, Shigeru ^c   Iseki, Kunitoshi ^c   Tsubakihara, Yoshiharu ^c   Fukuhara, Shunichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

Author keywords

Erythropoiesis stimulating agent responsiveness; hemodialysis; mortality

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; SERUM ALBUMIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; JAPAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; TREATMENT RESPONSE;

AGED; COHORT STUDIES; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RENAL DIALYSIS;

EID: 83655163838     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.07.014     Document Type: Article

References (41)

1. Y. Zhang, M. Thamer, K. Stefanik, J. Kaufman, D. Cotter Epoetin requirements predict mortality in hemodialysis patients Am J Kidney Dis 44 2004 866 876
2. R. Kilpatrick, C. Critchlow, S. Fishbane Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients Clin J Am Soc Nephrol 3 2008 1077 1083
3. J. López-Gómez, J. Portolés, P. Aljama Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality Kidney Int Suppl 111 2008 S75 S81
4. B. Robinson, M. Joffe, J. Berns, R. Pisoni, F. Port, H. Feldman Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time Kidney Int 68 2005 2323 2330
5. L. Szczech, H. Barnhart, J. Inrig Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes Kidney Int 74 2008 791 798
6. F. Locatelli, R. Pisoni, C. Combe Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 2004 121 132
7. G. Strippoli, S. Navaneethan, J. Craig Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease Cochrane Database Syst Rev 18 4 2006 CD003967
8. S. Palmer, S. Navaneethan, J. Craig Meta-analysis: erythropoiesis- stimulating agents in patients with chronic kidney disease Ann Intern Med 153 2010 23 33
9. National Kidney Foundation KDOQI, II Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Adults Am J Kidney Dis 47 5 suppl 3 2006 S16 S85
10. F. Locatelli, P. Aljama, P. Bárány Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure Nephrol Dial Transplant 19 suppl 2 2004 ii1 ii47
11. Y. Tsubakihara, S. Nishi, T. Akiba 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease Ther Apher Dial 14 2010 240 275
12. G. Kaysen, H. Mller, J. Ding, G. Chertow Challenging the validity of the EPO index Am J Kidney Dis 47 2006 157 166
13. P. McFarlane, R. Pisoni, M. Eichleay, R. Wald, F. Port, D. Mendelssohn International trends in erythropoietin use and hemoglobin levels in hemodialysis patients Kidney Int 78 2010 215 223
14. U. Verdalles, S. Abad, A. Vega Factors related to the absence of anemia in hemodialysis patients Blood Purif 32 2011 69 74
15. G. Birgegard Managing anemia in lymphoma and multiple myeloma Ther Clin Risk Manag 4 2008 527 539
16. K. Iseki, S. Nakai, K. Yamagata, Y. Tsubakihara Tachycardia as a predictor of poor survival in chronic haemodialysis patients Nephrol Dial Transplant 26 2011 963 969
17. T. Andersson, L. Alfredsson, H. Kallberg, S. Zdravkovic, A. Ahlbom Calculating measures of biological interaction Eur J Epidemiol 20 2005 575 579
18. R. Li, L. Chambless Test for additive interaction in proportional hazards models Ann Epidemiol 17 2007 227 236
19. J. Coladonato, D. Frankenfield, D. Reddan Trends in anemia management among US hemodialysis patients J Am Soc Nephrol 13 2002 1288 1295
20. D. Regidor, J. Kopple, C. Kovesdy Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients J Am Soc Nephrol 17 2006 1181 1191
21. K. Kalantar-Zadeh, G. Lee, J. Miller Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients Am J Kidney Dis 53 2009 823 834
22. P. Stenvinkel Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant 17 suppl 8 2002 33 38 discussion 40
23. J. Smrzova, J. Balla, P. Bárány Inflammation and resistance to erythropoiesis-stimulating agentswhat do we know and what needs to be clarified? Nephrol Dial Transplant 20 suppl 8 2005 viii2 viii7
24. A. Kadiroglu, E. Kadiroglu, D. Sit, A. Dag, M. Yilmaz Periodontitis is an important and occult source of inflammation in hemodialysis patients Blood Purif 24 2006 400 404
25. G. Nassar, S. Fishbane, J. Ayus Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients Kidney Int Suppl 80 2002 49 54
26. V. Maisnar, K. Chroust Treatment of associated anemia in different hematological disorders with epoetin alpha Neoplasma 51 2004 379 384
27. R. Abels Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer Semin Oncol 19 1992 29 35
28. K. Kalantar-Zadeh, T. Ikizler, G. Block, M. Avram, J. Kopple Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences Am J Kidney Dis 42 2003 864 881
29. K. Kalantar-Zadeh, C. McAllister, R. Lehn, G. Lee, A. Nissenson, J. Kopple Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients Am J Kidney Dis 42 2003 761 773
30. K. Kalantar-Zadeh, C. McAllister, R. Lehn, E. Liu, J. Kopple A low serum iron level is a predictor of poor outcome in hemodialysis patients Am J Kidney Dis 43 2004 671 684
31. K.J. Rothman Epidemiology: An Introduction 2002 Oxford University Press New York, NY
32. D. Hosmer, S. Lemeshow Confidence interval estimation of interaction Epidemiology 3 1992 452 456
33. B. Bradbury, O. Wang, C. Critchlow Exploring relative mortality and epoetin alfa dose among hemodialysis patients Am J Kidney Dis 51 2008 62 70
34. Y. Zhang, M. Thamer, D. Cotter, J. Kaufman, M. Hernán Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States Clin J Am Soc Nephrol 4 2009 638 644
35. B. Bradbury, M. Danese, M. Gleeson, C. Critchlow Effect of epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL Clin J Am Soc Nephrol 4 2009 630 637
36. B. Bradbury, T. Do, W. Winkelmayer, C. Critchlow, M. Brookhart Greater epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL Pharmacoepidemiol Drug Saf 18 2009 932 940
37. M.A. Brookhart, S. Schneeweiss, J. Avorn, B.D. Bradbury, J. Liu, W.C. Winkelmayer Comparative mortality risk of anemia management practices in incident hemodialysis patients JAMA 303 2010 857 864
38. P.A. McFarlane, R.L. Pisoni, M.A. Eichleay, R. Wald, F.K. Port, D. Mendelssohn International trends in erythropoietin use and hemoglobin levels in hemodialysis patients Kidney Int 78 2010 215 223
39. R.L. Pisoni, J.L. Bragg-Gresham, E.W. Young Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 44 2004 94 111
40. Y. Zhang, M. Thamer, K. Stefanik, J. Kaufman, D.J. Cotter Epoetin requirements predict mortality in hemodialysis patients Am J Kidney Dis 44 2004 866 876
41. D. Johnson, C. Pollock, I. Macdougall Erythropoiesis-stimulating agent hyporesponsiveness Nephrology (Carlton) 12 2007 321 330